Drug & supplement interaction

Myofascial Release + Panitumumab

Panitumumab brand name: Vectibix.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Myofascial Release and Panitumumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

Myofascial Release and Panitumumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Panitumumab and Myofascial Release in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Myofascial Release at all — not against Panitumumab, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Myofascial Release safety at a glance

Myofascial Release overall Use caution Generally low-risk when performed by a trained provider, but not right for everyone.
Pregnancy Use caution May be used with care, but only with a provider experienced in working with pregnant clients.
Breastfeeding Generally safe No known concerns for breastfeeding from this hands-on therapy.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Panitumumab and Myofascial Release? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Panitumumab’s Own FDA Label Lists

This is not an interaction — none of it involves Myofascial Release. These are the most notable effects listed in the ADVERSE REACTIONS section of Panitumumab’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • An electrolyte imbalance Worth acting on
  • Low magnesium Worth acting on
  • A bowel blockage Worth acting on
  • Dehydration Worth acting on
  • Low potassium Worth acting on
  • Blood clots Worth acting on
  • Wheezing Worth acting on
  • A severe skin reaction Worth acting on
  • Chest pain Worth acting on
  • Kidney problems Worth acting on

Showing the 10 most notable of 43 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Panitumumab. Read the label on DailyMed › Myofascial Release’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Myofascial Release side to compare — that is a limit of the record, not a statement that Myofascial Release has no side effects.

Everything else you take

See Every Supplement That Interacts With Panitumumab

This page covers Myofascial Release only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Panitumumab page lists 1 supplement it has a documented interaction with, worst first, each one explained.

The most serious there right now: American Pawpaw (minor).

By severity: 1 minor.

From our pharmacist’s overview on the Panitumumab page

“Panitumumab (Vectibix) is an infused antibody used against certain colorectal cancers, and its supplement interaction file is about as short as they come. A single ingredient appears on it, American pawpaw, and even that is rated minor, with the evidence suggesting the interaction is unlikely to occur at all.”

Reviewed by 2 · Jul 18, 2026

Open the Panitumumab interaction page

How much people look this up

Where Myofascial Release and Panitumumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Myofascial Release
Steady interest

#1,161 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Panitumumab
Steady interest

#2,518 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Myofascial Release is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Myofascial Release reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Myofascial Release and Panitumumab records this page draws on were last updated June 20, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Myofascial Release

What is Myofascial Release?

  • Muscle tightness and pain
  • Back and neck pain
  • Limited range of motion
  • Fibromyalgia symptoms
  • Tension headaches
  • Sports recovery

Myofascial release is a hands-on (or self-applied) manual therapy that uses gentle, sustained pressure to ease muscle and connective tissue tightness. It is not a supplement or herb, and while many people find it helpful for muscle pain and stiffness, the scientific evidence is mixed and limited. It is generally low-risk when done properly, but talk to a doctor or physical therapist before starting, especially if you have a medical condition.

Not applicable (manual therapy technique) · Hands-on therapy, foam rolling, massage balls, instrument-assisted tools

An interaction check asks whether these two react with each other — it does not ask whether Myofascial Release is a good idea for someone in your situation. Here is what our Myofascial Release record says about it on its own.

Myofascial Release: dosing

Because myofascial release is a manual therapy and not a supplement, there is no standardized "dose" in milligrams or pills. Treatment plans vary based on your needs, your provider, and your condition.In professional settings, sessions may last anywhere from a few minutes to an hour, and how often you go depends on your goals. For at-home self-release with a foam roller or ball, start gently and for short periods, and avoid rolling directly over joints, bones, or injured areas. Follow the guidance of a qualified physical therapist or provider, and check with a healthcare professional before starting a new routine.

From our Myofascial Release monograph — the full record covers uses, side effects and every documented interaction.

Read the full Myofascial Release monograph & all interactions
Medication

About Panitumumab Injection

What Is Panitumumab Injection Used For?

Brand name: Vectibix

Vectibix (panitumumab injection) is used to treat metastatic colorectal cancer (mCRC) in adults. It is approved for patients whose tumors have a specific genetic profile — either wild-type RAS (no RAS mutations in KRAS or NRAS) or a KRAS G12C mutation — as confirmed by an FDA-approved test before starting treatment.

For wild-type RAS mCRC, Vectibix may be used alone after prior chemotherapy has stopped working, or in combination with FOLFOX chemotherapy as a first-line treatment. For KRAS G12C-mutated mCRC, Vectibix is used in combination with sotorasib in patients who have already received fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy. Vectibix is not appropriate for patients with RAS-mutant mCRC (except in the specific KRAS G12C combination setting) or for patients whose RAS mutation status is unknown.

See full Panitumumab Injection drug information
Keep checking

Other Drugs & Myofascial Release

Browse every other medication we’ve checked against Myofascial Release — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Myofascial Release References

The 2 sources that drive our Myofascial Release monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Myofascial Release is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.

  1. Massage Therapy: What You Need To Know — NIH NCCIH Source
  2. Myofascial Release Therapy — Cleveland Clinic Source

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Myofascial Release and Panitumumab Together: Common Questions

Is it safe to take Myofascial Release with Panitumumab?
We do not list a known interaction between Myofascial Release and Panitumumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Does Panitumumab interact with any supplements?
Yes. Panitumumab has documented interactions with 1 supplement in our database — Myofascial Release is not one of them. The Panitumumab interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Panitumumab and Myofascial Release?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.